Some studies have demonstrated that lower levels of eGFR-cystatin C, relative to eGFR-creatinine, are associated with an increased risk of frailty, hospitalizations for heart failure, cardiovascular disease, kidney failure, and mortality. Here, CST3 is linked to cardiovascular disorder.